27 results
424B5
ITCI
Intra-Cellular Therapies Inc
5 Jan 22
Prospectus supplement for primary offering
4:51pm
and any of our product candidates that become a marketable product, if any, we will rely on our exclusivity under patents to sell the compound and recoup
424B5
ITCI
Intra-Cellular Therapies Inc
3 Jan 22
Prospectus supplement for primary offering
5:30pm
candidates that become a marketable product, if any, we will rely on our exclusivity under patents to sell the compound and recoup our investments
424B5
mclw5c7x8b3 64zjb
11 Sep 20
Prospectus supplement for primary offering
4:44pm
424B5
ca4d3qkz3be8zaw8h37v
9 Sep 20
Prospectus supplement for primary offering
4:40pm
424B5
kpwx16blf1rs8
8 Jan 20
Prospectus supplement for primary offering
5:06pm
8-K
EX-99.3
p0tji
6 Jan 20
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:52pm
424B5
6kbhx6 pbcpa3pqo2
6 Jan 20
Prospectus supplement for primary offering
4:42pm
S-3ASR
uy3nwcs
6 Jan 20
Automatic shelf registration
4:02pm
424B5
w4mjqofhu6puo5nq9hx9
6 Mar 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.3
3lvrgj3azfc3 09yz
4 Mar 15
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
12:00am
424B5
q2r g5q1k53b
4 Mar 15
Prospectus supplement for primary offering
12:00am